Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic hepatitis B: preventing, detecting, and managing viral resistance.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Mar 2008

Keeffe Emmet B, Dieterich Douglas T, Pawlotsky Jean-Michel, Benhamou Yves

Abstract excerpt

Licensed oral agents for antiviral therapy in patients with chronic hepatitis B virus (HBV) infection include lamivudine, adefovir, entecavir, and telbivudine. Emtricitabine, tenofovir, and the combination of tenofovir plus emtricitabine in 1 tablet, which are licensed for the treatment of human...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Mutation

Share to Virus Replication

Source

Identifiers

PMID: 18328434
DOI: 10.1016/j.cgh.2007.12.043

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18328434-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic hepatitis B: preventing, detecting, and managing viral resistance.PMID 18328434Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Viral resistance in hepatitis B: prevalence and management.Semantic proximity Read ↗

Hepatitis B: treatment choice and monitoring for response and resistance.Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Antiviral drug resistance: clinical consequences and molecular aspects.Semantic proximity Read ↗

[Management of antiviral-resistant chronic hepatitis B virus infection].Semantic proximity Read ↗

Update on hepatitis B virus infection.Semantic proximity Read ↗

Chronic hepatitis B therapy: available drugs and treatment guidelines.Semantic proximity Read ↗

Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments.Semantic proximity Read ↗

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.